- JP-listed companies
- WAKAMOTO PHARMACEUTICAL CO.,LTD.
- Financials
- Stockholders' equity
WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512)
Market cap
¥11.8B
P/E ratio
51.4x
Wakamoto Pharmaceutical manufactures branded drugs, generic medicines, and health products like Koryoku Wakamoto for healthcare providers and consumers in Japan and internationally.
| Period End | Stockholders' equity (Million JPY) | YoY (%) |
|---|---|---|
| Mar 31, 2026 | 12,009 | +3.43% |
| Mar 31, 2025 | 11,610 | -3.46% |
| Mar 31, 2024 | 12,026 | +1.00% |
| Mar 31, 2023 | 11,907 | +3.71% |
| Mar 31, 2022 | 11,481 | +0.84% |
| Mar 31, 2021 | 11,386 | -4.70% |
| Mar 31, 2020 | 11,947 | -13.18% |
| Mar 31, 2019 | 13,761 | -2.45% |
| Mar 31, 2018 | 14,107 | +1.52% |
| Mar 31, 2017 | 13,897 | -0.42% |
| Mar 31, 2016 | 13,955 | -1.20% |
| Mar 31, 2015 | 14,124 | +2.26% |
| Mar 31, 2014 | 13,813 |